| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|---|---|---|---|---|
Aetna
| Facility | $874.00 | $874.00 | $874.00 | |
Aetna
| Professional | $509.20 | $509.20 | $630.79 | |
United
| Professional | $319.20 | $456.00 | $1,672.00 |
Oncology (prostate), exosome-based analysis of 442 small noncoding RNAs (sncRNAs) by quantitative reverse transcription polymerase chain reaction (RT-qPCR), urine, reported as molecular evidence of no-, low-, intermediate- or high-risk of prostate cancer
| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|---|---|---|---|---|
Aetna
| Facility | $874.00 | $874.00 | $874.00 | |
Aetna
| Professional | $509.20 | $509.20 | $630.79 | |
United
| Professional | $319.20 | $456.00 | $1,672.00 |